When Novo Nordisk was developing its digital concierge chatbot Sophia, it noticed something: late-night spikes in online visits to Novo's Cornerstones for ...

The final—and the biggest—piece of Takeda’s $10 billion divestment plan could be wrapped up soon. The Japanese pharma is in the final stage of talks to s...

Despite Biogen's intense effort to defend its big-selling multiple sclerosis drug Tecfidera, Mylan has cleared several hurdles to launch a copycat, and now it's doin...

Despite hundreds of potential therapies for COVID-19 looking to make their case, very few have crossed the finish line. One promising candidate, Regeneron's two-anti...

After archrival Opdivo from Bristol Myers Squibb posted a pair of esophageal cancer wins last week, Merck & Co.’s Keytruda is determined not to be left behind. ...

August 19, 2020, Dusseldorf, Germany – MLM Medical Labs GmbH (“MLM”), a Great Point Partners (“GPP”) portfolio company, today announced that Isabel Struik has joined...

A new coronavirus contact tracing app is scheduled to begin public trials in England today to support the NHS Test and Trace service, the BBC has reported. The new...

UK-Austria-based biotech F2G has secured $60.8m in a new financing round to support late-stage development of a novel antifungal agent. The financing round was led...

The US Food and Drug Administration (FDA) has accepted Roche’s application for a new self-administration option for Xolair (omalizumab) across all approved US indica...

The FDA in recent years has been tough on cell and gene therapy makers, particularly when its comes to approving the labor-intensive and complicated manufacturi...